SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-022924
Filing Date
2020-08-19
Accepted
2020-08-19 16:19:51
Documents
2
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11418
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4602
  Complete submission text file 0000899243-20-022924.txt   17409
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Issuer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCHRODINGER, INC. 120 WEST 45TH STREET, 17TH FLOOR NEW YORK NY 10036
Business Address
Akinsanya Karen (Reporting) CIK: 0001797672 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39206 | Film No.: 201117296